Literature DB >> 7945302

Cyclin/cdk2 complexes in the nucleus of HeLa cells.

M Jaumot1, X Graña, A Giordano, P V Reddy, N Agell, O Bachs.   

Abstract

Two different fractions of cdk2 and cdc2 have been found in the nucleus of HeLa cells. One, which can be extracted by nuclease treatment, possibly associated with DNA- or RNA-containing structures and another one, which is bound to the nuclear matrix. Nuclear cdk2 forms high molecular weight complexes which migrate at the same position as DNA polymerase alpha and proliferating cell nuclear antigen in sucrose gradient centrifugation experiments. These results suggest that nuclear cdk2 complexes could be associated with the replication factories. Immunoprecipitation experiments reveal that nuclear cdk2 complexes display histone H1-kinase activity and phosphorylate a protein of 18 kDa which is present in these complexes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7945302     DOI: 10.1006/bbrc.1994.2359

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  Multiple roles for kinases in DNA replication.

Authors:  Ghislaine Henneke; Stéphane Koundrioukoff; Ulrich Hübscher
Journal:  EMBO Rep       Date:  2003-03       Impact factor: 8.807

2.  Cell cycle-dependent dynamic association of cyclin/Cdk complexes with human DNA replication proteins.

Authors:  Isabelle Frouin; Alessandra Montecucco; Giuseppe Biamonti; Ulrich Hübscher; Silvio Spadari; Giovanni Maga
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

3.  Subnuclear localization and mitotic phosphorylation of HIRA, the human homologue of Saccharomyces cerevisiae transcriptional regulators Hir1p/Hir2p.

Authors:  F De Lucia; S Lorain; C Scamps; F Galisson; J MacHold; M Lipinski
Journal:  Biochem J       Date:  2001-09-01       Impact factor: 3.857

4.  Role of androgen receptor in progression of LNCaP prostate cancer cells from G1 to S phase.

Authors:  Shalini Murthy; Min Wu; V Uma Bai; Zizheng Hou; Mani Menon; Evelyn R Barrack; Sahn-Ho Kim; G Prem-Veer Reddy
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.